Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark : A register-based study. / Nonboe, Mette Hartmann ; Napolitano, George; Schroll, Jeppe Bennekou; Vejborg, Ilse; Waldstrøm, Marianne; Lynge, Elsebeth.

In: eLife, Vol. 12, e81605, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nonboe, MH, Napolitano, G, Schroll, JB, Vejborg, I, Waldstrøm, M & Lynge, E 2023, 'Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study', eLife, vol. 12, e81605. https://doi.org/10.7554/eLife.81605

APA

Nonboe, M. H., Napolitano, G., Schroll, J. B., Vejborg, I., Waldstrøm, M., & Lynge, E. (2023). Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study. eLife, 12, [e81605]. https://doi.org/10.7554/eLife.81605

Vancouver

Nonboe MH, Napolitano G, Schroll JB, Vejborg I, Waldstrøm M, Lynge E. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study. eLife. 2023;12. e81605. https://doi.org/10.7554/eLife.81605

Author

Nonboe, Mette Hartmann ; Napolitano, George ; Schroll, Jeppe Bennekou ; Vejborg, Ilse ; Waldstrøm, Marianne ; Lynge, Elsebeth. / Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark : A register-based study. In: eLife. 2023 ; Vol. 12.

Bibtex

@article{97f6e8e87f724e08839ad97f4bf28d5b,
title = "Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study",
abstract = "Background:Denmark was one of the few countries where it was politically decided to continue cancer screening during the COVID-19 pandemic. We assessed the actual population uptake of mammography and cervical screening during this period.Methods:The first COVID-19 lockdown in Denmark was announced on 11 March 2020. To investigate possible changes in cancer screening activity due to the COVID-19 pandemic, we analysed data from the beginning of 2017 until the end of 2021. A time series analysis was carried out to discover possible trends and outliers in the screening activities in the period 2017–2021. Data on mammography screening and cervical screening were retrieved from governmental pandemic-specific monitoring of health care activities.Results:A brief drop was seen in screening activity right after the first COVID-19 lockdown, but the activity quickly returned to its previous level. A short-term deficit of 43% [CI –49 to –37] was found for mammography screening. A short-term deficit of 62% [CI –65 to –58] was found for cervical screening. Furthermore, a slight, statistically significant downward trend in cervical screening from 2018 to 2021 was probably unrelated to the pandemic. Other changes, for example, a marked drop in mammography screening towards the end of 2021, also seem unrelated to the pandemic.Conclusions:Denmark continued cancer screening during the pandemic, but following the first lockdown a temporary drop was seen in breast and cervical screening activity.",
author = "Nonboe, {Mette Hartmann} and George Napolitano and Schroll, {Jeppe Bennekou} and Ilse Vejborg and Marianne Waldstr{\o}m and Elsebeth Lynge",
year = "2023",
doi = "10.7554/eLife.81605",
language = "English",
volume = "12",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications Ltd.",

}

RIS

TY - JOUR

T1 - Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark

T2 - A register-based study

AU - Nonboe, Mette Hartmann

AU - Napolitano, George

AU - Schroll, Jeppe Bennekou

AU - Vejborg, Ilse

AU - Waldstrøm, Marianne

AU - Lynge, Elsebeth

PY - 2023

Y1 - 2023

N2 - Background:Denmark was one of the few countries where it was politically decided to continue cancer screening during the COVID-19 pandemic. We assessed the actual population uptake of mammography and cervical screening during this period.Methods:The first COVID-19 lockdown in Denmark was announced on 11 March 2020. To investigate possible changes in cancer screening activity due to the COVID-19 pandemic, we analysed data from the beginning of 2017 until the end of 2021. A time series analysis was carried out to discover possible trends and outliers in the screening activities in the period 2017–2021. Data on mammography screening and cervical screening were retrieved from governmental pandemic-specific monitoring of health care activities.Results:A brief drop was seen in screening activity right after the first COVID-19 lockdown, but the activity quickly returned to its previous level. A short-term deficit of 43% [CI –49 to –37] was found for mammography screening. A short-term deficit of 62% [CI –65 to –58] was found for cervical screening. Furthermore, a slight, statistically significant downward trend in cervical screening from 2018 to 2021 was probably unrelated to the pandemic. Other changes, for example, a marked drop in mammography screening towards the end of 2021, also seem unrelated to the pandemic.Conclusions:Denmark continued cancer screening during the pandemic, but following the first lockdown a temporary drop was seen in breast and cervical screening activity.

AB - Background:Denmark was one of the few countries where it was politically decided to continue cancer screening during the COVID-19 pandemic. We assessed the actual population uptake of mammography and cervical screening during this period.Methods:The first COVID-19 lockdown in Denmark was announced on 11 March 2020. To investigate possible changes in cancer screening activity due to the COVID-19 pandemic, we analysed data from the beginning of 2017 until the end of 2021. A time series analysis was carried out to discover possible trends and outliers in the screening activities in the period 2017–2021. Data on mammography screening and cervical screening were retrieved from governmental pandemic-specific monitoring of health care activities.Results:A brief drop was seen in screening activity right after the first COVID-19 lockdown, but the activity quickly returned to its previous level. A short-term deficit of 43% [CI –49 to –37] was found for mammography screening. A short-term deficit of 62% [CI –65 to –58] was found for cervical screening. Furthermore, a slight, statistically significant downward trend in cervical screening from 2018 to 2021 was probably unrelated to the pandemic. Other changes, for example, a marked drop in mammography screening towards the end of 2021, also seem unrelated to the pandemic.Conclusions:Denmark continued cancer screening during the pandemic, but following the first lockdown a temporary drop was seen in breast and cervical screening activity.

U2 - 10.7554/eLife.81605

DO - 10.7554/eLife.81605

M3 - Journal article

C2 - 36943035

VL - 12

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e81605

ER -

ID: 339886294